New hope for kids with pompe: enzyme combo trial opens
NCT ID NCT04808505
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tests a new treatment (cipaglucosidase alfa/miglustat) for children with infantile-onset Pompe disease, a rare genetic disorder that causes muscle weakness and heart problems. The trial includes children from 6 months to under 18 years old who have either never received enzyme therapy or have been on it before. The main goal is to check safety, especially infusion-related reactions, and see how well the body handles the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLYCOGEN STORAGE DISEASE TYPE II INFANTILE ONSET are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AOU Federico II
RECRUITINGNaples, 80131, Italy
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 54229, United States
-
Duke University Early Phase Research Unit
RECRUITINGDurham, North Carolina, 27710, United States
-
Erasmus MC, Sophia Kinderziekenhuis
RECRUITINGRotterdam, 3015 GD, Netherlands
-
Great Ormond Street Hospital for Children NHS Foundation Trust
RECRUITINGLondon, WC1N3JH, United Kingdom
-
National Taiwan University Hospital
WITHDRAWNTaipei, 100, Taiwan
-
SphinCS GmbH
RECRUITINGHöchheim, 65239, Germany
-
The Emory Clinic
RECRUITINGAtlanta, Georgia, 30322, United States
-
UPMC Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
University of Florida Clinical Research Center
RECRUITINGGainesville, Florida, 32610, United States
-
University of Utah, Clinical and Translational Sciences Institute
RECRUITINGSalt Lake City, Utah, 84108, United States
-
Universitätsklinikum Gießen und Marburg GmbH, Zentrum fur Kinderheilkunde und Jugendmedizin Abteilung fur Kinderneurologic, Sozialpadiatric und Epileptologie
RECRUITINGGiessen, 35392, Germany
-
Universitätsklinikum Heidelberg - Pädiatrisches Klinisch-Pharmakologisches Studienzentrum (paedKliPS)
RECRUITINGHeidelberg, 69120, Germany
-
Universitätsklinikum Münster Klinik für Kinder- und Jugendmedizin Albert-Schweitzer-Campus 1
RECRUITINGMünster, 48149, Germany
Conditions
Explore the condition pages connected to this study.